Sleep Disorders

Closed to enrollment
A 12-week multicenter study to assess the effectiveness of an investigational drug in comparison to a placebo for people with insomnia. The 12 week blinded study will be followed by a 40 week open study drug phase.

Be 18 years of age or older and have primary insomnia that impacts daytime functioning

Have Body Mass Index less than 32 and no history of sleep apnea, narcolepsy, or restless leg syndrome

Study medication and study related physical exam at no cost. Qualified participants will receive a stipend to cover time and travel.

view all clinical trials >>